【摘 要】
：
Background The adult myeloid diseases,myelodysplastic syndrome and acute myeloid leukemia,have been reported to be associated with cigarette smoking,but the results have been conflicting.
【机 构】
：
Department of Pathology,Medical Faculty,Kunming University of Science and Technology,Kunming,P.R.Chi
论文部分内容阅读
Background The adult myeloid diseases,myelodysplastic syndrome and acute myeloid leukemia,have been reported to be associated with cigarette smoking,but the results have been conflicting.
其他文献
Objectives Anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC) screening is essential to its treatment such as crizotinib.
Background Treatment of metastatic colon carcinoma with the anti-epidermal growth factor receptor antibody cetuximab/panitumumab is reported to be ineffective in KRAS-mutant tumors;therefore,it is nec
Introduction Crizotinib treatment can significantly prolong progression-free survival,increase response rates,and improve the quality of life in patients with advanced and ALK-positive non-small-cell
Background Papillary thyroid carcinoma (PTC) is the most usual histological type among thyroid cancer,accounts for approximately 80 ％,Although PTC is highly curable,some patients still encounter high
目的:研究CyclinD1 在宫颈上皮内瘤变及鳞状细胞癌中的表达规律及其与HPV16 E7 基因表达的相关性.方法:采用QT-PCR、免疫组织化学法检测CyclinD1 在子宫颈上皮内瘤变及鳞状细胞癌组织中基因及蛋白的表达;采用RT-PCR、Western blot、免疫组织化学方法检测CyclinD1 在不同E7 表达状态宫颈鳞癌细胞系中基因及蛋白表达;采用RT-PCR、Western blot
目的:通过分析HPV 感染类型﹑持续感染时间﹑病毒载量与宫颈癌病变的相关性,拟为宫颈癌预警系统的建立提供提供可靠的实验室证据.方法:回顾性1096例宫颈病变的患者,以TBS 诊断系统为临床诊断标准,分析宫颈上皮病变程度不同的患者中感染HPV 类型,持续时间,病毒载量高低差异.
目的 探讨NSCLC 组织中棘皮动物微管样蛋白4-间变淋巴瘤激酶(echinoderm microtubuleassociated protein like 4-anaplastic lymphoma kinase,EML4-ALK)融合基因与胸苷酸合成酶(thymidylate synthase,TYMS)mRNA 表达的关系.
目的 探讨NSCLC 组织中人表皮生长因子受体(epidermal growth factor receptor,EGFR)基因突变与切除修复交叉互补蛋白1(excision repair cross-complementation group 1,ERCC1)和核苷酸还原酶亚单位M1(ribonucleotide reductase subunit M1,RRM1)mRNA表达的关系.
目的:探讨非小细胞肺癌组织中RET 融合基因与胸苷酸合成酶(thymidylate synthase,TYMS)基因mRNA 表达的关系.方法:应用实时荧光定量PCR 方法检测642例NSCLC 组织中RET 基因以及TYMS 基因mRNA 的表达.
目的:探讨甲状腺癌患者肿瘤组织中BRAF 基因突变和RET 融合基因各亚型情况.方法:应用Taqman-ARMS 方法检测106例甲状腺癌肿瘤组织中BRAF 基因突变和RET 融合基因情况.